All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| 220485AB2 / Corsicanto Ii Designated Act Bond
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
| ATRS / Antares Pharma Inc
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| CNCE / Concert Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| SELB / Selecta Biosciences Inc
|
|
|
|
|
|
|
|
| DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| STRM / Streamline Health Solutions, Inc.
|
|
|
|
|
|
|
|
| RVNC / Revance Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CRBP / Corbus Pharmaceuticals Holdings, Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| ECYT / Endocyte, Inc.
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc. Call
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc. Put
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| SIOX / Sio Gene Therapies Inc.
|
|
|
|
|
|
|
|
| NVCR / NovoCure Limited
|
|
|
|
|
|
|
|
| CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc Call
|
|
|
|
|
|
|
|
| MYOV / Myovant Sciences Ltd
|
|
|
|
|
|
|
|
| CPRX / Catalyst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| 0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
| VYNE / VYNE Therapeutics Inc.
|
|
|
|
|
|
|
|
| ACOR / Acorda Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| ACOR / Acorda Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock) Call
|
|
|
|
|
|
|
|
| CNXR / Connecture, Inc.
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| SAGE / Sage Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PRTA / Prothena Corporation plc Call
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| RIGL / Rigel Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
